It seems Riluzole is not so effective as increasing median survival by up to 19 months.
There is an article online entitled: "Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055506/#:~:text=The%20results%20indicate%20that%20riluzole,longer%20than%20participants%20taking%20placebo.
"Riluzole 100 mg daily is reasonably safe and probably prolongs median survival by about two to three months in patients with amyotrophic lateral sclerosis."
Admittedly that was published back in 2012, so have there been more recent studies on the properties of Riluzole?
It seems Riluzole is not so effective as increasing median...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.020(8.89%) |
Mkt cap ! $96.99M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.5¢ | 22.5¢ | $150.8K | 649.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 50607 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
0.020 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 24.0¢ | 22.5¢ | 231366 | ||
| Last updated 15.56pm 17/06/2024 ? | |||||
| PAA (ASX) Chart |
